Taysha Gene Therapies(TSHA) - 2022 Q3 - Earnings Call Transcript

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2022 Results Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporate Affairs Officer RA Session - President, Founder and Chief Executive Officer Suyash Prasad - Chief Medical Officer and Head of Research and Development Kamran Alam - Chief Financial Officer Fred Porter - Chief Technical Officer Conference Call Participants Gil Blum - Needham & Company, LLC Geulah Livshits - Chardan Mehdi Goudarzi - Truist Securitie ...